NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1073812384 DO
Verify on CMS → Monica Plazarte, DO
Endocrinology, Diabetes & Metabolism Physician in Hudson, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 617 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
37%
generic claims · 54% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.9/100
▲ 2 pts above national avg 83.5 · Above neutral
Industry payments
$3.4K
126 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Monica Plazarte, DO reported a CMS MIPS final score of 85.9/100 - above the 83.5 national average - and filed 4,430 Medicare Part D claims in 2023.
- 85.9/100
- MIPS score · +2 vs avg
- 4K
- Part D claims, 2023
- 37%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1073812384 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1073812384
- ENUM-MID 2011
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-INLINE 85.9/100
- RX-MID 4,430
- BOOK-LIGHT 519 in Florida
- PHOTO-FINISH Yun Ying Shi · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Cristin Bruns · …
Cristin Bruns
85.8 MIPS pts
- Zeina Habib · near
Zeina Habib
85.8 MIPS pts
- Plazarte · this …
Plazarte · this provider
85.9 MIPS pts
- Yun Ying Shi · n…
Yun Ying Shi
85.9 MIPS pts
- Susan Ahern · hi…
Susan Ahern
86.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Monica Plazarte, DO's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
86 ≥ 46th percentile 46% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Monica Plazarte, DO sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Monica Plazarte, DO writes more Part D claims than 77% of them and scores higher on MIPS quality than 52% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Monica Plazarte, DO. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Monica Plazarte, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Monica Plazarte, DO?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
4,430 68% vs specialty avg
MIPS final score
85.9/100 2.4 pts vs avg
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Monica Plazarte, DO's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 85.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1073812384 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | DO |
| Gender | Female |
| NPI Issued | 03/25/2011 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
85.9345
Final Score
Measured-score avg: 83.5
73.995
Quality
87
Promoting Interoperability
Reporting: Individual
Hospital and facility affiliations
Facilities where Monica Plazarte, DO bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Diabetes Care Center, Inc
Hudson, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Monica Plazarte, DO. Source: openpaymentsdata.cms.gov.
Total received
$3.4K
Largest payer
Corcept Therapeutics
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Monica Plazarte, DO. To verify Monica Plazarte, DO's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Monica Plazarte, DO - brand share 54.0%
Endocrinology, Diabetes & Metabolism Physician average
54% brand-name claims vs 37% generic, on 4,430 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,430
Total Claims
$2.9M
Total Drug Cost
617
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 10,176
- Total Day Supply
- 302,142
- Brand vs Generic
- 54% brand / 37% generic
- Brand Drug Cost
- $2.7M
- Generic Drug Cost
- $63K
Patient Demographics
- Average Patient Age
- 70.0 years
- Avg HCC Risk Score
- 2.11
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 117, 65-74: 294, 75-84: 175, 85+: 31
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Monica Plazarte, DO prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
507 claims
- Ozempic
Ozempic
262 claims
- Metformin Hcl
Metformin Hcl
237 claims
- Trulicity
Trulicity
225 claims
- Glipizide Er 154
Glipizide Er
154 claims
- Novolog Flexpen 100
Novolog Flexpen
100 claims
- Synthroid 100
Synthroid
100 claims
- Tresiba Flextouch … 100
Tresiba Flextouch U-100
100 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 507 |
| Ozempic Semaglutide | 262 |
| Metformin Hcl | 237 |
| Trulicity Dulaglutide | 225 |
| Glipizide Er Glipizide | 154 |
| Novolog Flexpen Insulin Aspart | 100 |
| Synthroid Levothyroxine Sodium | 100 |
| Tresiba Flextouch U-100 Insulin Degludec | 100 |
| Rybelsus Semaglutide | 98 |
| Novolog Insulin Aspart | 94 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Monica Plazarte, DO fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Monica Plazarte, DO's 4,430 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Plazarte, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (85.9 here).
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Plazarte.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Monica Plazarte, DO's specialty? ▼
Monica Plazarte, DO specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Hudson, Florida. Credentials: DO.
How much does Monica Plazarte, DO prescribe under Medicare Part D? ▼
In 2023, Monica Plazarte, DO wrote 4,430 Medicare Part D claims totaling $2.9M in drug costs for 617 beneficiaries.
What is Monica Plazarte, DO's Medicare quality score? ▼
Monica Plazarte, DO has a CMS MIPS Final Score of 85.9/100 (Quality: 74). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Monica Plazarte, DO located? ▼
Monica Plazarte, DO is located at 14100 FIVAY RD, Hudson, FL, 34667. Phone: (727) 869-7822.
What is Monica Plazarte, DO's NPI number? ▼
Monica Plazarte, DO's National Provider Identifier (NPI) is 1073812384, issued on 03/25/2011.
Does Monica Plazarte, DO prescribe more brand-name or generic drugs? ▼
Monica Plazarte, DO's prescribing is 54% brand-name and 37% generic drugs by claim count, with $2.7M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Monica Plazarte, DO prescribe most often? ▼
Based on 2023 Medicare Part D data, Monica Plazarte, DO's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Monica Plazarte, DO accept Medicare? ▼
Monica Plazarte, DO appears in CMS Medicare data with 4,430 Part D claims and 617 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Monica Plazarte, DO's credentials? ▼
Monica Plazarte, DO's NPI is 1073812384 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.